Therefore, our data provide a link between high levels of MPO and increased lipid oxidation at the site of inflammation, pointing to the possibility that LPOs might be suitable new drug targets in future therapeutic approaches for COVID-19 patients with severe infection. The gene discussed is MPO; the disease is infection.